M. Nasir

Survival and Biomarkers of COVID-19 Patients Treated with Remdesivir and Favipiravir in ICU during the Peak of Pandemic: A Single Center Study in Bangladesh

M. Nasir, R. A. Perveen, M. Murshed, R. Nazneen & K. A. Talha · Journal of Pharmaceutical Research International · 2021

Since the first detection of a cluster of COVID-19 patients in China in late 2019, it becomes a global concern due to its transmissibility and ability to progress patients in severe respiratory failure and acute respiratory distress syndrome, which need intensive care unit suppor...

Open access Research Article 10.9734/jpri/2020/v32i4531088

Efficacy and Safety of Topical Permethrin, Oral Ivermectin Versus Combined Therapy in Scabies: A Randomized Controlled, Single Blind, Cross-sectional Study in Bangladesh

N. Islam, S. Mirza & M. Nasir · International Journal of TROPICAL DISEASE & Health · 2026

Background: Scabies is an intensely transmissible ectoparasitic skin infestation that continues to cause significant morbidity, particularly in populations with limited healthcare resources. Although topical permethrin 5% remains the standard first-line treatment, its clinical su...

Open access Research Article 10.9734/ijtdh/2026/v47i61753